These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1079029)

  • 1. Extractable nuclear antigen effect on the DNA anti-DNA reaction and NZB/NZW mouse nephritis.
    Morris AD; Littleton C; Corman LC; Esterly J; Sharp GC
    J Clin Invest; 1975 May; 55(5):903-7. PubMed ID: 1079029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tanned cell hemagglutination and counter immunoelectrophoresis test in the detection of antibodies to extractable nuclear antigens (ENA) and to DNA in the systemic lupus erythematosus.
    Depiante-Depaoli M; Galmarini M; Pesoa SA; Riera CM
    Ann Biol Clin (Paris); 1989; 47(5):247-51. PubMed ID: 2787132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
    Ando DG; Sercarz EE; Hahn BH
    J Immunol; 1987 May; 138(10):3185-90. PubMed ID: 2952711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H; Yoshida M; Izui S; Lambert PH
    J Clin Invest; 1985 Aug; 76(2):685-94. PubMed ID: 3875630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of anti-DNA antibodies in murine lupus nephritis.
    Granholm NA; Graves K; Izui S; Cavallo T
    J Clin Lab Immunol; 1985 Nov; 18(3):113-8. PubMed ID: 3878885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
    Song YW; Tsao BP; Hahn BH
    J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case control study of antibodies to ENA in progressive systemic sclerosis patients.
    Furst DE; Obrodovic M; Barnett EV; Clements PJ; Paulus HE
    J Rheumatol; 1984 Jun; 11(3):298-305. PubMed ID: 6610753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of IgG subclass antibodies anti-ENA (extractable nuclear antigens) in systemic rheumatic diseases.
    Sánchez Ibarrola A; Valdivieso R; Wong E; Sánchez Arroyo R
    Allergol Immunopathol (Madr); 1987; 15(4):195-200. PubMed ID: 3500626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA.
    Hahn BH; Ebling FM
    J Immunol; 1984 Jan; 132(1):187-90. PubMed ID: 6606665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenic role of antinuclear antibodies in lupus disease].
    Sany J
    Ann Med Interne (Paris); 1990; 141(3):222-6. PubMed ID: 2195947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.